EAF2 | ELL associated factor 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM111B | Family with sequence similarity 111, member B | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FYB | FYN binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GZMK | Granzyme K (granzyme 3; tryptase II) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
HIST1H3J | Histone cluster 1, H3j | Predicted intracellular proteins
| | | | | Tissue enhanced |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RG | Interleukin 2 receptor, gamma | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
KIAA0226L | KIAA0226-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PDCD1 | Programmed cell death 1 | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PTPN7 | Protein tyrosine phosphatase, non-receptor type 7 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | | | | Tissue enhanced |
PVRIG | Poliovirus receptor related immunoglobulin domain containing | Predicted membrane proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RCSD1 | RCSD domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SEPT1 | Septin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SKAP1 | Src kinase associated phosphoprotein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
STAP1 | Signal transducing adaptor family member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TBC1D10C | TBC1 domain family, member 10C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
THEMIS | Thymocyte selection associated | Predicted intracellular proteins
| | | | | Tissue enhanced |
TNFSF11 | Tumor necrosis factor (ligand) superfamily, member 11 | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TRAT1 | T cell receptor associated transmembrane adaptor 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TREML1 | Triggering receptor expressed on myeloid cells-like 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
UBD | Ubiquitin D | Predicted intracellular proteins
| | | | | Tissue enhanced |